Hisatoshi Sugiura
Overview
Explore the profile of Hisatoshi Sugiura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
1697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kimura N, Tsukita Y, Ebina-Shibuya R, Miyauchi E, Yamada M, Narita D, et al.
Cancer Biomark
. 2024 Apr;
PMID: 38669521
Background: Biomarkers predicting clinical outcomes of treating non-small cell lung cancer (NSCLC) with combination of immune checkpoint inhibitors (ICIs) and chemotherapy would be valuable. Objective: This study aims to seek...
12.
Koarai A, Yamada M, Ichikawa T, Fujino N, Sugiura H
Respir Investig
. 2024 Apr;
62(3):503-511.
PMID: 38599052
Background: For the treatment of COPD exacerbations, systemic corticosteroids are recommended in addition to short-acting bronchodilators. Although there have been several systemic reviews, many of the included studies were conducted...
13.
Saito T, Fujino N, Kyogoku Y, Yamada M, Okutomo K, Ono Y, et al.
Am J Physiol Lung Cell Mol Physiol
. 2024 Mar;
326(6):L672-L686.
PMID: 38530936
Alveolar macrophages (AMs) in patients with chronic obstructive pulmonary disease (COPD) orchestrate persistent inflammation in the airway. However, subpopulations of AMs participating in chronic inflammation have been poorly characterized. We...
14.
Sano H, Fujino N, Numakura T, Yamada M, Tode N, Sugiura H
Ann Am Thorac Soc
. 2024 Jan;
21(3):526-529.
PMID: 38285591
No abstract available.
15.
Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, et al.
Sci Rep
. 2024 Jan;
14(1):165.
PMID: 38168544
An inhibitor of plasminogen activator inhibitor (PAI)-1, TM5614, inhibited thrombosis, inflammation, and fibrosis in several experimental mouse models. To evaluate the efficacy and safety of TM5614 in human COVID-19 pneumonia,...
16.
Tamada T, Sugiura H
Respir Investig
. 2023 Oct;
61(6):815-823.
PMID: 37806235
Despite evidence-based guidelines and the availability of five biologics in Japan to treat severe asthma, approximately one-third of patients with severe asthma continue to have uncontrolled disease. This lack of...
17.
Shibata Y, Kawayama T, Muro S, Sugiura H
Respir Investig
. 2023 Sep;
61(6):773-780.
PMID: 37741092
Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction on spirometry and symptoms such as dyspnea on exertion and chronic cough with sputum production, thus making it a significant...
18.
Ito T, Ichikawa T, Yamada M, Hashimoto Y, Fujino N, Numakura T, et al.
Allergol Int
. 2023 Aug;
73(1):151-163.
PMID: 37607853
Background: 27-Hydroxycholesterol (27-HC) derived from sterol 27-hydroxylase (CYP27A1) has pro-inflammatory biological activity and is associated with oxidative stress and chronic inflammation in COPD. However, the role of regulation of CYP27A1-...
19.
Ono Y, Tsukita Y, Fujino N, Sugiura H
Intern Med
. 2023 Aug;
63(6):881-882.
PMID: 37532544
No abstract available.
20.
Matsunaga T, Sano H, Takita K, Morita M, Yamanaka S, Ichikawa T, et al.
Nat Commun
. 2023 Jul;
14(1):4476.
PMID: 37491435
Supersulphides are inorganic and organic sulphides with sulphur catenation with diverse physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA synthetase (CARS2) that functions as a principal cysteine persulphide...